Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified
Conditions
Interventions
Intervention1: Electroacupuncture: Participants in the study group (35 patients) lying in prone position will receive
electroacupuncture at the Spleen Back-Shu point (BL20-bilateral) from 9:00 AM to 1
Sponsors
Dr Praveena M N
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who were diagnosed with dyslipidemia, (Serum Total Cholesterol greater than or equal to 200 mg per dl or Serum LDL greater than 100 mg per dl or Serum HDL less than 60 mg per dl or Triglyceride level greater than or equal to 150 mg per dL (as per NCEP-ATP III guidelines). 3. Participants who have diagnosed with dyslipidemia of more than 1 month. 4. Participants who have also under medication for more than 1 month.
Exclusion criteria
Exclusion criteria: 1. Secondary dyslipidemia due to Hypothyroidism, Nephrotic syndrome, Cushing s syndrome. 2. History of cardiovascular events (e.g., myocardial infarction, stroke) within the past 6 months. 3. Patients who undergone any cardiovascular surgery (Placement of coronary stent or pacemaker). 4. Participation in any other clinical trial within the past 3 months. 5. Known seizure disorders, or psychiatric illness interfering with study compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome measure will be the change in serum lipid profile from baseline to the end of the 4th week intervention period. Fasting blood samples (after 10 12 hours of overnight fasting) will be collected and analyzed using standard enzymatic colorimetric methods. Measurements will be taken at baseline (Week 0) and post-intervention (Week 4). The primary endpoint is the mean reduction in total cholesterol in the study group compared to the control group.Timepoint: Baseline,1st week and 4th week | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes of this study include changes in Blood Pressure and Body Mass Index from baseline to the end of the 4-week intervention. Participants systolic and diastolic blood pressure will be recorded using standard calibrated digital sphygmomanometers under resting conditions. Measurements will be taken at consistent times of day to reduce variability and ensure accuracy. Both biochemical and physiological outcome measures will be compared within and between the study and control groups to determine the broader impact of chrono-electroacupuncture on metabolic health and cardiovascular function.Timepoint: Baseline,1st week and 4th week | — |
Countries
India
Contacts
Public ContactDr S Geetanjali
International Institute of Yoga and Naturopathy Medical Sciences
Outcome results
None listed